ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/08/26 | 1,523 | 1,523 | 1,481 | 1,488 | -30 | -2% | 67,400 |
2016/08/25 | 1,533 | 1,541 | 1,511 | 1,518 | -14 | -0.9% | 41,000 |
2016/08/24 | 1,545 | 1,545 | 1,523 | 1,532 | -8 | -0.5% | 32,600 |
2016/08/23 | 1,524 | 1,553 | 1,522 | 1,540 | +16 | +1% | 62,600 |
2016/08/22 | 1,524 | 1,537 | 1,519 | 1,524 | +9 | +0.6% | 35,900 |
2016/08/19 | 1,509 | 1,522 | 1,504 | 1,515 | +2 | +0.1% | 56,600 |
2016/08/18 | 1,525 | 1,532 | 1,513 | 1,513 | -29 | -1.9% | 54,600 |
2016/08/17 | 1,550 | 1,557 | 1,526 | 1,542 | -10 | -0.6% | 69,800 |
2016/08/16 | 1,593 | 1,593 | 1,552 | 1,552 | -39 | -2.5% | 53,900 |
2016/08/15 | 1,628 | 1,632 | 1,590 | 1,591 | -39 | -2.4% | 42,300 |
2016/08/12 | 1,629 | 1,632 | 1,616 | 1,630 | +14 | +0.9% | 44,600 |
2016/08/10 | 1,610 | 1,621 | 1,604 | 1,616 | +3 | +0.2% | 43,900 |
2016/08/09 | 1,606 | 1,619 | 1,590 | 1,613 | -8 | -0.5% | 47,400 |
2016/08/08 | 1,635 | 1,635 | 1,597 | 1,621 | +12 | +0.7% | 63,100 |
2016/08/05 | 1,639 | 1,640 | 1,587 | 1,609 | +72 | +4.7% | 183,400 |
2016/08/04 | 1,502 | 1,544 | 1,502 | 1,537 | -5 | -0.3% | 91,700 |
2016/08/03 | 1,573 | 1,576 | 1,522 | 1,542 | -46 | -2.9% | 93,000 |
2016/08/02 | 1,600 | 1,615 | 1,585 | 1,588 | -18 | -1.1% | 34,900 |
2016/08/01 | 1,604 | 1,617 | 1,585 | 1,606 | -21 | -1.3% | 48,000 |
2016/07/29 | 1,591 | 1,631 | 1,571 | 1,627 | +36 | +2.3% | 83,500 |
2016/07/28 | 1,633 | 1,638 | 1,570 | 1,591 | -43 | -2.6% | 101,800 |
2016/07/27 | 1,658 | 1,666 | 1,627 | 1,634 | -8 | -0.5% | 82,300 |
2016/07/26 | 1,643 | 1,652 | 1,613 | 1,642 | -1 | -0.1% | 78,000 |
2016/07/25 | 1,670 | 1,670 | 1,630 | 1,643 | -2 | -0.1% | 91,100 |
2016/07/22 | 1,631 | 1,656 | 1,622 | 1,645 | +3 | +0.2% | 59,500 |
2016/07/21 | 1,670 | 1,671 | 1,640 | 1,642 | -18 | -1.1% | 83,600 |
2016/07/20 | 1,670 | 1,690 | 1,646 | 1,660 | +6 | +0.4% | 180,300 |
2016/07/19 | 1,590 | 1,665 | 1,590 | 1,654 | +86 | +5.5% | 229,800 |
2016/07/15 | 1,604 | 1,604 | 1,562 | 1,568 | -30 | -1.9% | 51,800 |
2016/07/14 | 1,583 | 1,609 | 1,579 | 1,598 | +20 | +1.3% | 54,100 |
2016/07/13 | 1,620 | 1,620 | 1,573 | 1,578 | -8 | -0.5% | 75,400 |
2016/07/12 | 1,611 | 1,623 | 1,584 | 1,586 | -22 | -1.4% | 80,300 |
2016/07/11 | 1,601 | 1,628 | 1,587 | 1,608 | +64 | +4.1% | 77,700 |
2016/07/08 | 1,629 | 1,640 | 1,544 | 1,544 | -64 | -4% | 135,100 |
2016/07/07 | 1,588 | 1,622 | 1,588 | 1,608 | +20 | +1.3% | 164,800 |
2016/07/06 | 1,520 | 1,591 | 1,519 | 1,588 | +51 | +3.3% | 210,500 |
2016/07/05 | 1,525 | 1,540 | 1,517 | 1,537 | -4 | -0.3% | 36,200 |
2016/07/04 | 1,534 | 1,555 | 1,526 | 1,541 | +18 | +1.2% | 46,300 |
2016/07/01 | 1,485 | 1,534 | 1,485 | 1,523 | +46 | +3.1% | 61,600 |
2016/06/30 | 1,510 | 1,525 | 1,476 | 1,477 | -29 | -1.9% | 72,900 |
2016/06/29 | 1,500 | 1,517 | 1,476 | 1,506 | +25 | +1.7% | 50,600 |
2016/06/28 | 1,442 | 1,500 | 1,428 | 1,481 | +9 | +0.6% | 71,600 |
2016/06/27 | 1,405 | 1,480 | 1,405 | 1,472 | +80 | +5.7% | 78,600 |
2016/06/24 | 1,540 | 1,550 | 1,379 | 1,392 | -132 | -8.7% | 98,600 |
2016/06/23 | 1,539 | 1,540 | 1,506 | 1,524 | -4 | -0.3% | 40,500 |
2016/06/22 | 1,558 | 1,560 | 1,505 | 1,528 | -52 | -3.3% | 66,900 |
2016/06/21 | 1,536 | 1,586 | 1,522 | 1,580 | +37 | +2.4% | 129,600 |
2016/06/20 | 1,482 | 1,550 | 1,476 | 1,543 | +91 | +6.3% | 147,800 |
2016/06/17 | 1,490 | 1,505 | 1,452 | 1,452 | -13 | -0.9% | 112,400 |
2016/06/16 | 1,435 | 1,478 | 1,435 | 1,465 | +38 | +2.7% | 180,900 |
2201~
2250
件表示中 / 3772件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,000円 | +3.1% | -6.5% | 2.36% | 9.42倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 312,500円 | +5.1% | -7.0% | 2.56% | 20.51倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,300円 | +4.1% | -3.1% | 2.35% | 21.48倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 151,400円 | -2.4% | -52.3% | 3.76% | 18.12倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム